Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

A Review of Chronic Leukoencephalopathy among Survivors of Childhood Cancer.

Partap S, Russo S, Esfahani B, Yeom K, Mazewski C, Embry L, Wheeler G, Ullrich NJ, Bowers DC.

Pediatr Neurol. 2019 Mar 21. pii: S0887-8994(18)31330-4. doi: 10.1016/j.pediatrneurol.2019.03.006. [Epub ahead of print] Review.

PMID:
31047756
2.

Molecular Grouping and Outcomes of Young Children with Newly Diagnosed Ependymoma Treated on the Multi-Institutional SJYC07 Trial.

Upadhyaya SA, Robinson GW, Onar-Thomas A, Orr BA, Billups CA, Bowers DC, Bendel AE, Hassall T, Crawford JR, Partap S, Fisher PG, Tatevossian RG, Seah T, Qaddoumi IA, Vinitsky A, Armstrong GT, Sabin ND, Tinkle CL, Klimo P, Indelicato DJ, Boop FA, Merchant TE, Ellison DW, Gajjar A.

Neuro Oncol. 2019 Apr 12. pii: noz069. doi: 10.1093/neuonc/noz069. [Epub ahead of print]

PMID:
30976811
3.

Design, synthesis, and molecular docking study of benzothiazolotriazine derivatives for anticonvulsant potential.

Firdaus JU, Habib A, Siddiqui N, Alam O, Naim MJ, Partap S, Sahu M.

Arch Pharm (Weinheim). 2018 Dec;351(12):e1800154. doi: 10.1002/ardp.201800154. Epub 2018 Nov 27.

PMID:
30479053
4.

ACR Appropriateness Criteria® Sinusitis-Child.

Expert Panel on Pediatric Imaging:, Tekes A, Palasis S, Durand DJ, Pruthi S, Booth TN, Desai NK, Jones JY, Kadom N, Lam HFS, Milla SS, Mirsky DM, Partap S, Robertson RL, Ryan ME, Saigal G, Setzen G, Soares BP, Trout AT, Whitehead MT, Karmazyn B.

J Am Coll Radiol. 2018 Nov;15(11S):S403-S412. doi: 10.1016/j.jacr.2018.09.029.

PMID:
30392608
5.

Cerebrospinal fluid vasopressin and symptom severity in children with autism.

Oztan O, Garner JP, Partap S, Sherr EH, Hardan AY, Farmer C, Thurm A, Swedo SE, Parker KJ.

Ann Neurol. 2018 Oct;84(4):611-615. doi: 10.1002/ana.25314. Epub 2018 Sep 26.

PMID:
30152888
6.

Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.

Robinson GW, Rudneva VA, Buchhalter I, Billups CA, Waszak SM, Smith KS, Bowers DC, Bendel A, Fisher PG, Partap S, Crawford JR, Hassall T, Indelicato DJ, Boop F, Klimo P, Sabin ND, Patay Z, Merchant TE, Stewart CF, Orr BA, Korbel JO, Jones DTW, Sharma T, Lichter P, Kool M, Korshunov A, Pfister SM, Gilbertson RJ, Sanders RP, Onar-Thomas A, Ellison DW, Gajjar A, Northcott PA.

Lancet Oncol. 2018 Jun;19(6):768-784. doi: 10.1016/S1470-2045(18)30204-3. Epub 2018 May 16.

7.

A phase 1/2 dose-finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous system.

Manley PE, Trippett T, Smith AA, Macy ME, Leary SES, Boklan J, Cohen KJ, Goldman S, Kilburn LB, Dhall G, Devin J, Herzog CE, Partap S, Fauchet F, Badreddine E, Bernard JP, Chi SN.

Pediatr Blood Cancer. 2018 Sep;65(9):e27217. doi: 10.1002/pbc.27217. Epub 2018 May 11.

PMID:
29750396
8.

ACR Appropriateness Criteria® Headache-Child.

Expert Panel on Pediatric Imaging:, Hayes LL, Palasis S, Bartel TB, Booth TN, Iyer RS, Jones JY, Kadom N, Milla SS, Myseros JS, Pakalnis A, Partap S, Robertson RL, Ryan ME, Saigal G, Soares BP, Tekes A, Karmazyn BK.

J Am Coll Radiol. 2018 May;15(5S):S78-S90. doi: 10.1016/j.jacr.2018.03.017.

PMID:
29724429
9.

Arginine vasopressin in cerebrospinal fluid is a marker of sociality in nonhuman primates.

Parker KJ, Garner JP, Oztan O, Tarara ER, Li J, Sclafani V, Del Rosso LA, Chun K, Berquist SW, Chez MG, Partap S, Hardan AY, Sherr EH, Capitanio JP.

Sci Transl Med. 2018 May 2;10(439). pii: eaam9100. doi: 10.1126/scitranslmed.aam9100.

PMID:
29720452
10.

Synthesis of stable benzimidazole derivatives bearing pyrazole as anticancer and EGFR receptor inhibitors.

Akhtar MJ, Khan AA, Ali Z, Dewangan RP, Rafi M, Hassan MQ, Akhtar MS, Siddiqui AA, Partap S, Pasha S, Yar MS.

Bioorg Chem. 2018 Aug;78:158-169. doi: 10.1016/j.bioorg.2018.03.002. Epub 2018 Mar 3.

PMID:
29571113
11.

Pediatric neuro-oncology survival disparities in California.

Cooney T, Fisher PG, Tao L, Clarke CA, Partap S.

J Neurooncol. 2018 May;138(1):83-97. doi: 10.1007/s11060-018-2773-0. Epub 2018 Feb 7.

PMID:
29417400
12.

Pyridazinone hybrids: Design, synthesis and evaluation as potential anticonvulsant agents.

Partap S, Akhtar MJ, Yar MS, Hassan MZ, Siddiqui AA.

Bioorg Chem. 2018 Apr;77:74-83. doi: 10.1016/j.bioorg.2018.01.001. Epub 2018 Jan 3.

PMID:
29334622
13.

Irreversible growth plate fusions in children with medulloblastoma treated with a targeted hedgehog pathway inhibitor.

Robinson GW, Kaste SC, Chemaitilly W, Bowers DC, Laughton S, Smith A, Gottardo NG, Partap S, Bendel A, Wright KD, Orr BA, Warner WC, Onar-Thomas A, Gajjar A.

Oncotarget. 2017 Sep 1;8(41):69295-69302. doi: 10.18632/oncotarget.20619. eCollection 2017 Sep 19.

14.

Design, Synthesis, and Pharmacological Screening of Pyridazinone Hybrids as Anticonvulsant Agents.

Partap S, Yar MS, Hassan MZ, Akhtar MJ, Siddiqui AA.

Arch Pharm (Weinheim). 2017 Oct;350(10). doi: 10.1002/ardp.201700135. Epub 2017 Sep 1.

PMID:
28863231
15.

Pediatric cancer risk in association with birth defects: A systematic review.

Johnson KJ, Lee JM, Ahsan K, Padda H, Feng Q, Partap S, Fowler SA, Druley TE.

PLoS One. 2017 Jul 27;12(7):e0181246. doi: 10.1371/journal.pone.0181246. eCollection 2017. Review.

16.

ACR Appropriateness Criteria® Suspected Physical Abuse-Child.

Expert Panel on Pediatric Imaging:, Wootton-Gorges SL, Soares BP, Alazraki AL, Anupindi SA, Blount JP, Booth TN, Dempsey ME, Falcone RA Jr, Hayes LL, Kulkarni AV, Partap S, Rigsby CK, Ryan ME, Safdar NM, Trout AT, Widmann RF, Karmazyn BK, Palasis S.

J Am Coll Radiol. 2017 May;14(5S):S338-S349. doi: 10.1016/j.jacr.2017.01.036. Review.

PMID:
28473090
17.

ACR Appropriateness Criteria® Back Pain-Child.

Expert Panel on Pediatric Imaging:, Booth TN, Iyer RS, Falcone RA Jr, Hayes LL, Jones JY, Kadom N, Kulkarni AV, Myseros JS, Partap S, Reitman C, Robertson RL, Ryan ME, Saigal G, Soares BP, Tekes-Brady A, Trout AT, Zumberge NA, Coley BD, Palasis S.

J Am Coll Radiol. 2017 May;14(5S):S13-S24. doi: 10.1016/j.jacr.2017.01.039. Review.

PMID:
28473069
18.

Pediatric Ependymoma.

Vitanza NA, Partap S.

J Child Neurol. 2016 Oct;31(12):1354-66. doi: 10.1177/0883073815610428. Epub 2015 Oct 26. Review.

PMID:
26503805
19.

Arginine Vasopressin Is a Blood-Based Biomarker of Social Functioning in Children with Autism.

Carson DS, Garner JP, Hyde SA, Libove RA, Berquist SW, Hornbeak KB, Jackson LP, Sumiyoshi RD, Howerton CL, Hannah SL, Partap S, Phillips JM, Hardan AY, Parker KJ.

PLoS One. 2015 Jul 22;10(7):e0132224. doi: 10.1371/journal.pone.0132224. eCollection 2015.

20.

Hypoxia-mimicking bioactive glass/collagen glycosaminoglycan composite scaffolds to enhance angiogenesis and bone repair.

Quinlan E, Partap S, Azevedo MM, Jell G, Stevens MM, O'Brien FJ.

Biomaterials. 2015 Jun;52:358-66. doi: 10.1016/j.biomaterials.2015.02.006. Epub 2015 Mar 3.

PMID:
25818442
21.

Decreased tumor apparent diffusion coefficient correlates with objective response of pediatric low-grade glioma to bevacizumab.

Hsu CH, Lober RM, Li MD, Partap S, Murphy PA, Barnes PD, Fisher PG, Yeom KW.

J Neurooncol. 2015 May;122(3):491-6. doi: 10.1007/s11060-015-1754-9. Epub 2015 Mar 11.

PMID:
25758812
22.

Cerebrospinal fluid and plasma oxytocin concentrations are positively correlated and negatively predict anxiety in children.

Carson DS, Berquist SW, Trujillo TH, Garner JP, Hannah SL, Hyde SA, Sumiyoshi RD, Jackson LP, Moss JK, Strehlow MC, Cheshier SH, Partap S, Hardan AY, Parker KJ.

Mol Psychiatry. 2015 Sep;20(9):1085-90. doi: 10.1038/mp.2014.132. Epub 2014 Nov 4.

PMID:
25349162
23.

Childhood brain tumor epidemiology: a brain tumor epidemiology consortium review.

Johnson KJ, Cullen J, Barnholtz-Sloan JS, Ostrom QT, Langer CE, Turner MC, McKean-Cowdin R, Fisher JL, Lupo PJ, Partap S, Schwartzbaum JA, Scheurer ME.

Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2716-36. doi: 10.1158/1055-9965.EPI-14-0207. Epub 2014 Sep 5. Review.

24.

Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients.

Vera-Bolanos E, Aldape K, Yuan Y, Wu J, Wani K, Necesito-Reyes MJ, Colman H, Dhall G, Lieberman FS, Metellus P, Mikkelsen T, Omuro A, Partap S, Prados M, Robins HI, Soffietti R, Wu J, Gilbert MR, Armstrong TS; CERN Foundation.

Neuro Oncol. 2015 Mar;17(3):440-7. doi: 10.1093/neuonc/nou162. Epub 2014 Aug 13.

25.

MRI surrogates for molecular subgroups of medulloblastoma.

Perreault S, Ramaswamy V, Achrol AS, Chao K, Liu TT, Shih D, Remke M, Schubert S, Bouffet E, Fisher PG, Partap S, Vogel H, Taylor MD, Cho YJ, Yeom KW.

AJNR Am J Neuroradiol. 2014 Jul;35(7):1263-9. doi: 10.3174/ajnr.A3990. Epub 2014 May 15.

26.

Surveillance imaging in children with malignant CNS tumors: low yield of spine MRI.

Perreault S, Lober RM, Carret AS, Zhang G, Hershon L, Décarie JC, Vogel H, Yeom KW, Fisher PG, Partap S.

J Neurooncol. 2014 Feb;116(3):617-23. doi: 10.1007/s11060-013-1347-4. Epub 2014 Jan 9.

PMID:
24401959
27.

Novel microhydroxyapatite particles in a collagen scaffold: a bioactive bone void filler?

Lyons FG, Gleeson JP, Partap S, Coghlan K, O'Brien FJ.

Clin Orthop Relat Res. 2014 Apr;472(4):1318-28. doi: 10.1007/s11999-013-3438-0. Epub 2014 Jan 3.

28.

Time-dependent structural changes of the dentatothalamic pathway in children treated for posterior fossa tumor.

Perreault S, Lober RM, Cheshier S, Partap S, Edwards MS, Yeom KW.

AJNR Am J Neuroradiol. 2014 Apr;35(4):803-7. doi: 10.3174/ajnr.A3735. Epub 2013 Sep 19.

29.

Increased focal hemosiderin deposition in pediatric medulloblastoma patients receiving radiotherapy at a later age.

Yeom KW, Lober RM, Partap S, Telischak N, Tsolinas R, Barnes PD, Edwards MS.

J Neurosurg Pediatr. 2013 Nov;12(5):444-51. doi: 10.3171/2013.7.PEDS1330. Epub 2013 Aug 30.

PMID:
23992236
30.

Relapse patterns in pediatric embryonal central nervous system tumors.

Perreault S, Lober RM, Carret AS, Zhang G, Hershon L, Décarie JC, Yeom K, Vogel H, Fisher PG, Partap S.

J Neurooncol. 2013 Nov;115(2):209-15. doi: 10.1007/s11060-013-1213-4. Epub 2013 Aug 7.

PMID:
23921420
31.

Prognostic role for diffusion-weighted imaging of pediatric optic pathway glioma.

Yeom KW, Lober RM, Andre JB, Fisher PG, Barnes PD, Edwards MS, Partap S.

J Neurooncol. 2013 Jul;113(3):479-83. doi: 10.1007/s11060-013-1140-4. Epub 2013 May 15.

PMID:
23673514
32.

Distinctive MRI features of pediatric medulloblastoma subtypes.

Yeom KW, Mobley BC, Lober RM, Andre JB, Partap S, Vogel H, Barnes PD.

AJR Am J Roentgenol. 2013 Apr;200(4):895-903. doi: 10.2214/AJR.12.9249.

PMID:
23521467
33.

Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system.

Raghunathan A, Wani K, Armstrong TS, Vera-Bolanos E, Fouladi M, Gilbertson R, Gajjar A, Goldman S, Lehman NL, Metellus P, Mikkelsen T, Necesito-Reyes MJ, Omuro A, Packer RJ, Partap S, Pollack IF, Prados MD, Robins HI, Soffietti R, Wu J, Miller CR, Gilbert MR, Aldape KD; Collaborative Ependymoma Research Network.

Brain Pathol. 2013 Sep;23(5):584-94. doi: 10.1111/bpa.12050. Epub 2013 Mar 28.

PMID:
23452038
34.

Concurrent cyclophosphamide and craniospinal radiotherapy for pediatric high-risk embryonal brain tumors.

Campen CJ, Dearlove J, Partap S, Murphy P, Gibbs IC, Dahl GV, Fisher PG.

J Neurooncol. 2012 Nov;110(2):287-91. doi: 10.1007/s11060-012-0969-2. Epub 2012 Sep 2.

PMID:
22941430
35.

Stroke and cerebrovascular complications in childhood cancer survivors.

Partap S.

Semin Pediatr Neurol. 2012 Mar;19(1):18-24. doi: 10.1016/j.spen.2012.02.012. Review.

PMID:
22641072
36.

Birth anomalies and obstetric history as risks for childhood tumors of the central nervous system.

Partap S, MacLean J, Von Behren J, Reynolds P, Fisher PG.

Pediatrics. 2011 Sep;128(3):e652-7. doi: 10.1542/peds.2010-3637. Epub 2011 Aug 8.

37.

Three hours of perfusion culture prior to 28 days of static culture, enhances osteogenesis by human cells in a collagen GAG scaffold.

Keogh MB, Partap S, Daly JS, O'Brien FJ.

Biotechnol Bioeng. 2011 May;108(5):1203-10. doi: 10.1002/bit.23032. Epub 2011 Jan 25.

PMID:
21165906
38.

Effect of chronic red cell transfusion therapy on vasculopathies and silent infarcts in patients with sickle cell disease.

Gyang E, Yeom K, Hoppe C, Partap S, Jeng M.

Am J Hematol. 2011 Jan;86(1):104-6. doi: 10.1002/ajh.21901.

39.

The synthesis and characterization of nanophase hydroxyapatite using a novel dispersant-aided precipitation method.

Cunniffe GM, O'Brien FJ, Partap S, Levingstone TJ, Stanton KT, Dickson GR.

J Biomed Mater Res A. 2010 Dec 15;95(4):1142-9. doi: 10.1002/jbm.a.32931. Epub 2010 Sep 28.

PMID:
20878985
40.

Liposomal cytarabine for central nervous system embryonal tumors in children and young adults.

Partap S, Murphy PA, Vogel H, Barnes PD, Edwards MS, Fisher PG.

J Neurooncol. 2011 Jul;103(3):561-6. doi: 10.1007/s11060-010-0419-y. Epub 2010 Sep 22.

PMID:
20859651
41.

Birth weight and order as risk factors for childhood central nervous system tumors.

MacLean J, Partap S, Reynolds P, Von Behren J, Fisher PG.

J Pediatr. 2010 Sep;157(3):450-5. doi: 10.1016/j.jpeds.2010.04.006. Epub 2010 Jun 1.

PMID:
20553692
42.

IV.1. Scaffolds & surfaces.

Partap S, Lyons F, O'Brien FJ.

Stud Health Technol Inform. 2010;152:187-201. No abstract available.

PMID:
20407195
43.

Development and characterisation of a collagen nano-hydroxyapatite composite scaffold for bone tissue engineering.

Cunniffe GM, Dickson GR, Partap S, Stanton KT, O'Brien FJ.

J Mater Sci Mater Med. 2010 Aug;21(8):2293-8. doi: 10.1007/s10856-009-3964-1. Epub 2009 Dec 20.

PMID:
20091099
44.

Stimulation of osteoblasts using rest periods during bioreactor culture on collagen-glycosaminoglycan scaffolds.

Partap S, Plunkett NA, Kelly DJ, O'Brien FJ.

J Mater Sci Mater Med. 2010 Aug;21(8):2325-30. doi: 10.1007/s10856-009-3966-z. Epub 2009 Dec 20.

PMID:
20091098
45.

Medulloblastoma incidence has not changed over time: a CBTRUS study.

Partap S, Curran EK, Propp JM, Le GM, Sainani KL, Fisher PG.

J Pediatr Hematol Oncol. 2009 Dec;31(12):970-1. doi: 10.1097/MPH.0b013e3181bbc502.

PMID:
19887963
46.

Neurological complications in children.

Partap S, Fisher PG.

Cancer Treat Res. 2009;150:133-43. doi: 10.1007/b109924_9. Review. No abstract available.

PMID:
19834666
47.

Osteoblast response to rest periods during bioreactor culture of collagen-glycosaminoglycan scaffolds.

Plunkett NA, Partap S, O'Brien FJ.

Tissue Eng Part A. 2010 Mar;16(3):943-51. doi: 10.1089/ten.TEA.2009.0345.

PMID:
19827912
48.

Cerebrovascular disease in childhood cancer survivors: A Children's Oncology Group Report.

Morris B, Partap S, Yeom K, Gibbs IC, Fisher PG, King AA.

Neurology. 2009 Dec 1;73(22):1906-13. doi: 10.1212/WNL.0b013e3181c17ea8. Epub 2009 Oct 7. Review.

49.

Levetiracetam for seizures in children with brain tumors and other cancers.

Partap S, Fisher PG.

Pediatr Blood Cancer. 2009 Feb;52(2):288-9. doi: 10.1002/pbc.21772.

PMID:
18831033
50.

Part 1: scaffolds and surfaces.

Lyons F, Partap S, O'Brien FJ.

Technol Health Care. 2008;16(4):305-17. No abstract available.

PMID:
18776607

Supplemental Content

Loading ...
Support Center